Ovince St. Preux has accepted a three-month sanction for violation of the UFC Anti-Doping Policy according to a USADA press release. OSP tested positive for ostarine metabolites with what may have been a contaminated supplement.
Via USADA press release:
Saint Preux, 36, tested positive for ostarine and di-hydroxy-LGD-4033, a metabolite of LGD-4033, as well GW1516 sulfone and GW1516 sulfoxide, which are metabolites of GW1516 (also known as GW-501516), as the result of an out-of-competition urine sample he provided on November 1, 2019. Ostarine and LGD-4033 are non-Specified Substances in the class of Anabolic Agents, while GW1516 is a non-Specified Substance in the category of Hormone and Metabolic Modulators. These substances are prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.
During an investigation into the circumstances of the positive test, Saint Preux provided sealed containers of products he was using for analysis at the World Anti-Doping Agency-accredited laboratory in Salt Lake City, Utah. Although no prohibited substances were listed on the supplement labels, the analysis revealed that the products contained ostarine, LGD-4033, and GW1516 for which Saint Preux tested positive.
OSP’s last fight was a win against Michał Oleksiejczuk this past September in Denmark.
Payout Perspective:
OSP’s short sanction relates to the latest revisions to the UFC Anti-Doping Policy where an athlete may demonstrate by clear and convincing evidence that the cause of the positive test was due to a supplement certified by one of the certifiers in the UFC rules, they will be granted leniency so long as they can show no performance enhancing benefit. The 3-month sanction is relatively miniscule that prior sanctions where athletes claim a tainted supplement caused the failed drug test.
Leave a Reply